Antioxidants 2018, 7(9), 115; https://doi.org/10.3390/antiox7090115
The Use of Intravenous Vitamin C as a Supportive Therapy for a Patient with Glioblastoma Multiforme
1
Integrated Health Options Ltd., Auckland 1050, New Zealand
2
Department of Pathology & Biomedical Science, University of Otago, Christchurch 8140, New Zealand
3
Feedback Research Ltd., Auckland 1050, New Zealand
*
Author to whom correspondence should be addressed.
Received: 6 August 2018 / Revised: 21 August 2018 / Accepted: 28 August 2018 / Published: 30 August 2018
(This article belongs to the Special Issue Vitamin C: Current Concepts in Human Physiology)
Abstract
Glioblastoma multiforme is a high grade malignant brain tumour with a poor prognosis. Here we report the case of a woman with glioblastoma who lived for over four years from diagnosis (median survival 12 months and 2% survival for three years), experiencing good quality of life for most of that time. She underwent initial debulking craniotomy, radiotherapy and chemotherapy, as well as having intravenous vitamin C infusions 2–3 times weekly over the four years from diagnosis. Her progress was monitored by blood tests, regular computerised tomography (CT) and magnetic resonance imaging (MRI) scans, clinical reviews and European Organization for the Research and Treatment of Cancer quality of life questionnaires (EORTC QLQ C30). Our case report highlights the benefits of intravenous vitamin C as a supportive therapy for patients with glioblastoma. View Full-TextKeywords:
vitamin C; intravenous vitamin C; ascorbic acid; glioblastoma; neoplasms; quality of life
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
Baillie, N.; Carr, A.C.; Peng, S. The Use of Intravenous Vitamin C as a Supportive Therapy for a Patient with Glioblastoma Multiforme. Antioxidants 2018, 7, 115.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Related Articles
Article Metrics
Comments
[Return to top]
Antioxidants
EISSN 2076-3921
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert